X

Vous n'êtes pas connecté

Maroc Maroc - ZACKS.COM - All Stories - 01/Jul 12:00

PTC Therapeutics (PTCT) Down on Negative CHMP Opinion on DMD Drug

PTC Therapeutics (PTCT) falls as the EC's advisory committee adopts a negative opinion regarding the renewal of the conditional marketing approval of Translarna to treat nmDMD in the EU.

Articles similaires

Sorry! Image not available at this time

Apellis (APLS) Falls on Second Negative CHMP Opinion for GA Drug

zacks.com - 01/Jul 12:44

Apellis (APLS) declines as CHMP issues a second negative opinion for the approval of intravitreal pegcetacoplan to treat GA in the EU. The company...

Sorry! Image not available at this time

PTC Therapeutics (PTCT) Soars 9.7%: Is Further Upside Left in the Stock?

zacks.com - 24/Jun 08:44

PTC Therapeutics (PTCT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions...

Sorry! Image not available at this time

SEC recommends grant of permission to import and market Eli Lilly's weight loss drug

pharmabiz.com - 01/Jul 00:00

The Subject Expert Committee (SEC), which advises the national drug regulator on drugs and trials approval matters, has recommended grant of...

Sorry! Image not available at this time

Regeneron (REGN) Gets Positive CHMP Opinion for Lymphoma Drug

zacks.com - 01/Jul 12:57

Regeneron (REGN) gets positive CHMP recommendation for odronextamab for the treatment of adults with relapsed/refractory follicular lymphoma or...

Sorry! Image not available at this time

FDA Expands Approval for Duchenne Muscular Dystrophy Gene Therapy

drugs.com - 24/Jun 21:21

MONDAY, June 24, 2024 -- The U.S. Food and Drug Administration has expanded the approval of Elevidys (delandistrogene moxeparvovec-rokl), a gene...

Sorry! Image not available at this time

Pfizer (PFE), BioNTech's Updated COVID-19 Jab Gets CHMP Nod

zacks.com - 28/Jun 15:02

Pfizer (PFE) and BioNTech's Omicron JN.1-adapted COVID-19 vaccine gets the Committee for Medicinal Products for Human Use's positive opinion...

Sorry! Image not available at this time

AstraZeneca (AZN) Imfinzi Combo Gets CHMP Nod for Expanded Use

zacks.com - 02/Jul 15:00

The CHMP recommends approval of AstraZeneca's (AZN) Imfinzi plus Lynparza for treating primary advanced or recurrent endometrial cancer based on data...

Sorry! Image not available at this time

AstraZeneca (AZN) Imfinzi Combo Gets CHMP Nod for Expanded Use

zacks.com - 02/Jul 15:00

The CHMP recommends approval of AstraZeneca's (AZN) Imfinzi plus Lynparza for treating primary advanced or recurrent endometrial cancer based on data...

Sorry! Image not available at this time

Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab

zacks.com - 03/Jul 12:34

Eli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be the second drug on the market to treat the...

Arafura completes debt finance for huge rare earths play

aumanufacturing.com.au - 04/Jul 14:59

Arafura Rare Earths has secured conditional approval for up to US$115 million in loan guarantees from a German inter-ministerial committee – the...